清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

New Emerging Targets in Cancer Immunotherapy: The Role of B7-H3

免疫疗法 单克隆抗体 医学 放射免疫疗法 癌症免疫疗法 免疫系统 癌症 癌症研究 抗体 免疫检查点 免疫学 内科学
作者
Ioannis‐Alexios Koumprentziotis,Charalampos Theocharopoulos,Dimitra Foteinou,Erasmia Angeli,Amalia N. Anastasopoulou,Helen J Gogas,Dimitrios C. Ziogas
出处
期刊:Vaccines [Multidisciplinary Digital Publishing Institute]
卷期号:12 (1): 54-54 被引量:37
标识
DOI:10.3390/vaccines12010054
摘要

Immune checkpoints (ICs) are molecules implicated in the fine-tuning of immune response via co-inhibitory or co-stimulatory signals, and serve to secure minimized host damage. Targeting ICs with various therapeutic modalities, including checkpoint inhibitors/monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), and CAR-T cells has produced remarkable results, especially in immunogenic tumors, setting a paradigm shift in cancer therapeutics through the incorporation of these IC-targeted treatments. However, the large proportion of subjects who experience primary or secondary resistance to available IC-targeted options necessitates further advancements that render immunotherapy beneficial for a larger patient pool with longer duration of response. B7-H3 (B7 Homolog 3 Protein, CD276) is a member of the B7 family of IC proteins that exerts pleiotropic immunomodulatory effects both in physiologic and pathologic contexts. Mounting evidence has demonstrated an aberrant expression of B7-H3 in various solid malignancies, including tumors less sensitive to current immunotherapeutic options, and has associated its expression with advanced disease, worse patient survival and impaired response to IC-based regimens. Anti-B7-H3 agents, including novel mAbs, bispecific antibodies, ADCs, CAR-T cells, and radioimmunotherapy agents, have exhibited encouraging antitumor activity in preclinical models and have recently entered clinical testing for several cancer types. In the present review, we concisely present the functional implications of B7-H3 and discuss the latest evidence regarding its prognostic significance and therapeutic potential in solid malignancies, with emphasis on anti-B7-H3 modalities that are currently evaluated in clinical trial settings. Better understanding of B7-H3 intricate interactions in the tumor microenvironment will expand the oncological utility of anti-B7-H3 agents and further shape their role in cancer therapeutics.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
含糊的盼波完成签到,获得积分10
3秒前
呆呆的猕猴桃完成签到 ,获得积分10
12秒前
辛勤的松完成签到,获得积分10
22秒前
42秒前
宇文雨文完成签到 ,获得积分10
46秒前
靓丽的伟祺完成签到,获得积分10
1分钟前
俊逸吐司完成签到 ,获得积分10
1分钟前
1分钟前
可爱的一兰完成签到,获得积分10
1分钟前
周辰完成签到,获得积分10
1分钟前
djx发布了新的文献求助10
1分钟前
xiaojunsong完成签到 ,获得积分10
1分钟前
1分钟前
执着访云完成签到,获得积分10
1分钟前
少年完成签到 ,获得积分10
1分钟前
欢喜的诗珊完成签到,获得积分10
2分钟前
Imran完成签到,获得积分10
2分钟前
忧伤的傲芙完成签到,获得积分10
2分钟前
2分钟前
含蓄的雪冥完成签到,获得积分10
2分钟前
2分钟前
狂野的含烟完成签到 ,获得积分10
2分钟前
PDIF-CN2完成签到,获得积分10
2分钟前
执着语琴完成签到,获得积分10
2分钟前
顺心尔冬完成签到,获得积分10
3分钟前
3分钟前
3分钟前
whuhustwit完成签到,获得积分10
3分钟前
3分钟前
欣心发布了新的文献求助10
3分钟前
明亮的依珊完成签到,获得积分10
4分钟前
4分钟前
n01W97的应助被念姬采纳,获得20
4分钟前
兴奋筮完成签到,获得积分10
4分钟前
4分钟前
余又完成签到 ,获得积分10
4分钟前
科研通AI6.3的应助被RZH采纳,获得10
4分钟前
4分钟前
4分钟前
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173225
求助须知:如何正确求助?哪些是违规求助? 9565575
关于积分的说明 21780525
捐赠科研通 7767395
什么是DOI,文献DOI怎么找? 3431542
关于科研通互助平台的介绍 2555764
邀请新用户注册赠送积分活动 2476697